Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

The long-term neurologic consequences of COVID-19

by Medical Finance
in Coronavirus
Viewpoint: Nervous system consequences of COVID-19. Image Credit: DesignPrax/ Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A team of researchers recently provided insights into central nervous system consequences of the coronavirus disease 2019 (COVID-19) in a perspective paper published in the Science journal.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19, has been described as a respiratory pathogen, albeit the manifestation of extra-pulmonary symptoms in many COVID-19 patients, including nervous-system-related complications and neuromuscular disorders.

Some patients present with persistent symptoms like headaches, sensory disturbance, impaired concentration, depression, and psychosis after several months of contracting SARS-CoV-2, which is now described as a long-form of COVID-19 or long COVID. Acute COVID-19 and long COVID can occur even in the younger population who initially present with mild symptoms. Much needs to be learned about long COVID as its pathophysiological mechanisms remain poorly understood.

While the early evidence points to the immune dysfunction, including non-specific neuroinflammation, and anti-neural autoimmune dysregulation, it remains to be ascertained if any unforeseen neurological complications that might develop and persist for years after initial COVID-19 infection.

Viewpoint: Nervous system consequences of COVID-19. Image Credit: DesignPrax/ Shutterstock

Viewpoint: Nervous system consequences of COVID-19. Image Credit: DesignPrax/ Shutterstock

Preliminary findings reported changes in cognitive abilities

Initial studies of neurological syndromes associated with COVID-19 noted changes in cognitive functions weakness in hospitalized patients, while other investigations observed inflammation or demyelination of the central nervous system (CNS) or peripheral nervous system (PNS). With the growing number of SARS-CoV-2 infections, there was mounting evidence of extra-respiratory disorders affecting multiple organ systems in COVID-19 patients.

A study of hospitalized patients in the United Kingdom (UK) showed that the frequently recorded neurological symptoms were anosmia (loss of smell), stroke, encephalopathy, inflammation of the brain, delirium, peripheral nerve syndromes, and primary psychiatric syndromes.

No evidence of SARS-CoV-2 RNA or antigen in CSF and brain

Studies examining the cerebrospinal fluid (CSF) of living COVID-19 patients have failed to detect viral RNA by reverse transcription-polymerase chain reaction (RT-PCR). Consistent with this finding, histological analyses of brain tissue of patients who died due to acute COVID-19 showed that only limited viral RNA or protein could be detected.

CSF samples examined from living patients with acute COVID-19 revealed neuroinflammation and upregulation of interferon (IFN)-regulated genes in dendritic cells. In addition, the autopsy of acute COVID-19 patients showed the activation of microglia across the brain and the infiltration of macrophages and CD8 T cells in perivascular regions.

Although single-cell analysis of brain tissue confirmed microglial activation and infiltration of T cells, there was no evidence of SARS-CoV-2 RNA in brain parenchymal cells. Although the robust immune response seen in the CNS could not be supported, a transient SARS-CoV-2 infection of brain tissue has been suggested.

Long COVID: The manifestation of persistent symptoms after acute COVID-19

Patients with acute COVID-19 have described persistent syndromes that are now known as long Covid. Most symptoms are neurologic that include memory and concentration difficulties, frequent headaches, autonomic dysfunction, intractable fatigue, delusions, and paranoia. People experiencing these symptoms are mostly below 50 years of age and were healthy before contracting COVID-19, and a majority of them were never hospitalized for acute COVID-19.

Studies have shown similarities of long COVID symptoms with those observed in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Unfortunately, like long COVID, ME/CFS too is poorly understood and lacks effective disease-modifying therapies (DMTs), and more research into Long Covid could also be advantageous for ME/CFS patients.

An online study that involved 3,762 participants with long COVID noted that many of them had lingering symptoms for up to seven months after initial infection. In addition, imaging studies identified focal regions of brain atrophy in COVID-19 patients that were not seen in a control group without COVID-19 history. This could serve as a potential biomarker for the brain effects of SARS-CoV-2. Moreover, positron emission tomography (PET) scan of patients with COVID showed impaired metabolic activity of the brain, but its pathophysiology remains unknown.

The observation of neuroinflammation and neuronal injury has raised concerns over the potential development of neurodegenerative diseases (Alzheimer’s or Parkinson’s disease) in the future due to acute COVID-19.

Long COVID is not documented in children because they develop mild symptoms of COVID-19 and fewer neurological disorders. Still, those with a multi-system inflammatory syndrome in children (MIS-C) might be at a higher risk of nervous-system-related complications.

To summarize, more research is required to establish the pathophysiology of neurological complications that linger after COVID-19 infection and to effectively develop therapeutic interventions to mitigate the effects of Long COVID.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function. Image Credit: Naeblys/Shutterstock

Impact of clustered mutations in SARS-CoV-2 Omicron spike function

by Medical Finance
May 29, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers explored the characteristics of severe acute respiratory syndrome coronavirus...

Study: “Never let a good crisis go to waste”: Positives from disrupted maternity care in Australia during COVID-19. Image Credit: Prostock-studio/Shutterstock

Positive effects of altered maternal care during COVID-19 in Australia

by Medical Finance
May 29, 2022
0

In a recent study published in Midwifery, researchers reported on the positive outcomes of the coronavirus disease 2019 (COVID-19) pandemic...

Study: Omicron infection enhances Delta antibody immunity in vaccinated persons. Image Credit: NIAID

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

by Medical Finance
May 29, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant that was first identified in South Africa and Botswana in...

Researchers create a DNA-based fluorescent nanoantenna to monitor the motions of proteins

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

by Medical Finance
May 29, 2022
0

Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is...

Study: Persistent post-COVID-19 smell loss is associated with inflammatory infiltration and altered olfactory epithelial gene expression. Image Credit: megaflopp/Shutterstock

Persistent loss of smell after COVID-19 associated with altered olfactory epithelial gene expression

by Medical Finance
May 28, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers performed histology of the olfactory epithelium (OE) for smell...

Crucial regulator of malaria parasite transmission identified

History, facts and the future

by Medical Finance
May 28, 2022
0

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with...

Next Post
Study: The changing impact of vaccines in the COVID-19 pandemic. Image Credit: Ramcreative / Shutterstock.com

Impact of new COVID vaccinations as novel variants emerge

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: A broad and potent neutralization epitope in SARS-related coronaviruses. Image Credit: Andrii Vodolazhskyi/Shutterstock
    Study explores SARS-CoV-2 spike epitope with potent and broad neutralization
  • Study: Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial. Image Credit: Double Brain/Shutterstock
    Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply